Automated Detection of Dosing Errors in Clinical Trial Narratives: A Multi-Modal Feature Engineering Approach with LightGBM
About
Clinical trials require strict adherence to medication protocols, yet dosing errors remain a persistent challenge affecting patient safety and trial integrity. We present an automated system for detecting dosing errors in unstructured clinical trial narratives using gradient boosting with comprehensive multi-modal feature engineering. Our approach combines 3,451 features spanning traditional NLP (TF-IDF, character n-grams), dense semantic embeddings (all-MiniLM-L6v2), domain-specific medical patterns, and transformer-based scores (BiomedBERT, DeBERTa-v3), used to train a LightGBM model. Features are extracted from nine complementary text fields (median 5,400 characters per sample) ensuring complete coverage across all 42,112 clinical trial narratives. On the CT-DEB benchmark dataset with severe class imbalance (4.9% positive rate), we achieve 0.8725 test ROC-AUC through 5-fold ensemble averaging (cross-validation: 0.8833 + 0.0091 AUC). Systematic ablation studies reveal that removing sentence embeddings causes the largest performance degradation (2.39%), demonstrating their critical role despite contributing only 37.07% of total feature importance. Feature efficiency analysis demonstrates that selecting the top 500-1000 features yields optimal performance (0.886-0.887 AUC), outperforming the full 3,451-feature set (0.879 AUC) through effective noise reduction. Our findings highlight the importance of feature selection as a regularization technique and demonstrate that sparse lexical features remain complementary to dense representations for specialized clinical text classification under severe class imbalance.